Library›Substances and pharmacology›The Amplification Framework

The Amplification Framework

The Amplification Framework is a three-component model of supplement and nootropic design proposed by Rev. Ryan Sasha-Shai Van Kush in September 2021 (Plant Medicine for Humans: L-MethylFolate, Blurt/@punicwax, 18 September 2021) and expanded in the Institute's February 2026 revision.

Its claim is that optimal synthesis of a target molecule requires not one active agent but three functional roles filled at once.

The three components

{| class="wikitable"

! Role !! Function !! Monoamine example

|-

| 1. Substrate provider || supplies the raw molecular input || L-tryptophan, L-tyrosine, L-phenylalanine

|-

| 2. Cofactor amplifier || regenerates or supplies the cofactor that activates the enzyme || L-Methylfolate — regenerates BH4 via the salvage pathway

|-

| 3. Degradation inhibitor || prevents breakdown of the product or the cofactor || vitamin C (reduces the BH3 radical back to BH4); antioxidants

|}

How it was arrived at

By noticing a structural parallel. The cholinergic stack is long established in nootropic practice, and it has exactly this shape:

{| class="wikitable"

! Role !! Cholinergic stack (established) !! Monoamine stack (proposed)

|-

| Substrate || alpha-GPC — choline source || L-tryptophan / L-tyrosine

|-

| Modulator || piracetam / phenylpiracetam — receptor sensitiser || L-Methylfolate — BH4 cofactor regeneration

|-

| Degradation inhibitor || acetylcholinesterase inhibitors, antioxidants || vitamin C, L-carnosine

|}

The framework's assertion is that the monoamine column had a hole in the modulator row, and that L-methylfolate fills it.

Why this is the same idea as the cannabinoid work

The Cannabinoid Oilahuasca framework is the degradation-inhibitor row taken on its own and pursued to its conclusion: rather than supplying an agonist, inhibit MAGL and FAAH so that the ligand the body already makes persists longer. The classical ayahuasca combination — DMT plus an MAO inhibitor — is the same structure again, one row of substrate and one of degradation inhibitor. The Amplification Framework is the general statement of which those are instances.

Extended application

The paper proposes that L-methylfolate's efficacy is optimised alongside amino-acid substrates (L-tyrosine, L-phenylalanine, L-tryptophan), cofactor support (B12, B6, B2, iron), antioxidant protection (vitamin C, L-carnosine) and neuroprotective agents (astragalus / cycloastragenol).

Status

This is an independent theoretical contribution, not an established model. The individual mechanisms it composes are published; the framework itself is the author's, and the specific claim that filling all three roles outperforms filling one has not been tested in a trial. It is a design heuristic with a clear rationale, and it should be read as that.

See also: L-Methylfolate · Racetams · Choline Donors · Cannabinoid Oilahuasca · Stack Substances

Filed under  Substances and pharmacology